Rosetta Genomics (Rosetta Genomics) Net Margin % : -238.05% (As of Jun. 2017)

Rosetta Genomics Net Margin % Chart

Rosetta Genomics Annual Data
	Trend	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16
Net Margin %		Get a 7-Day Free Trial					-5,202.49	-3,184.44	-1,094.65	-209.78	-175.80

Rosetta Genomics Quarterly Data
	Dec10	Mar11	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17
Net Margin %	Get a 7-Day Free Trial															-155.09	-839.85	-180.27	-239.57	-238.05

Competitive Comparison of Rosetta Genomics's Net Margin %

For the Diagnostics & Research subindustry, Rosetta Genomics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rosetta Genomics's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rosetta Genomics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Rosetta Genomics's Net Margin % falls into.

Rosetta Genomics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Rosetta Genomics's Net Margin for the fiscal year that ended in Dec. 2016 is calculated as

Rosetta Genomics's Net Margin for the quarter that ended in Jun. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rosetta Genomics  (OTCPK:ROSGQ) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Rosetta Genomics Net Margin % Related Terms

Thank you for viewing the detailed overview of Rosetta Genomics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rosetta Genomics (Rosetta Genomics) Business Description